Table 4. The association of quartiles of total cholesterol with lower lean body mass in cancer patients.
| Male | Female | Total | |
|---|---|---|---|
| Total lean body mass | |||
| Model I† | |||
| 1st Quartile | Ref | Ref | Ref |
| 2nd Quartile | +3.40* (-0.39, 7.19) | -0.46 (-0.88, -0.04)∥ | -0.26 (-1.30, 0.78) |
| 3rd Quartile | -0.65 (-5.45, 4.15) | -0.67 (-1.61, 0.28) | -1.20 (-1.79, -0.60)¶ |
| 4th Quartile | -2.60 (-6.38, 1.18) | -3.04 (-3.49, -2.59)¶ | -3.15 (-3.58, -2.73)¶ |
| Model II‡ | |||
| 1st Quartile | Ref | Ref | Ref |
| 2nd Quartile | +3.00 (-1.19, 7.20) | -0.43 (-0.89, 0.03) | -0.98 (-1.91, -0.05)∥ |
| 3rd Quartile | -0.05 (-5.27, 5.18) | -0.23 (-1.10, 0.63) | -1.13 (-1.63, -0.64)¶ |
| 4th Quartile | -1.84 (-5.77, 2.08) | -3.08 (-3.41, -2.74)¶ | -3.14 (-3.44, -2.84)¶ |
| Model III§ | |||
| 1st Quartile | Ref | Ref | Ref |
| 2nd Quartile | +3.14 (-1.43, 7.70) | -0.23 (-0.58, 0.13) | -0.85 (-1.78, 0.07) |
| 3rd Quartile | +1.38 (-3.61, 6.37) | -0.20 (-1.00, 0.59) | -1.07 (-1.56, -0.58)¶ |
| 4th Quartile | -1.21 (-5.38, 2.96) | -3.37 (-3.75, -2.99)¶ | -3.23 (-3.62, -2.83)¶ |
| Appendicular lean body mass | |||
| Model I† | |||
| 1st Quartile | Ref | Ref | Ref |
| 2nd Quartile | -0.05 (-0.27, 0.18) | +2.37 (0.03, 4.70) | -0.28 (-1.95, 1.38 ) |
| 3rd Quartile | -0.26 (-0.80, 0.28) | +0.29 (-2.67, 3.25) | -0.37 (-2.09, 1.34) |
| 4th Quartile | -1.47 (-1.70, -1.24)¶ | -0.07 (-2.72, 2.58) | -1.81 (-3.23, -0.38)∥ |
| Model II‡ | |||
| 1st Quartile | Ref | Ref | Ref |
| 2nd Quartile | -0.09 (-0.32, 0.14) | +2.67 (0.34, 5.00) | -0.21 (-2.04, 1.62) |
| 3rd Quartile | -0.05 (-0.51, 0.42) | +0.85 (-1.94, 3.64) | -0.16 (-1.99, 1.67) |
| 4th Quartile | -1.48 (-1.65, -1.31)¶ | +0.66 (-1.79, 3.11) | -1.49 (-2.93, -0.05)∥ |
| Model III§ | |||
| 1st Quartile | Ref | Ref | Ref |
| 2nd Quartile | +0.04 (-0.15, 0.23) | +2.67 (1.01, 4.33)∥ | +0.19 (-1.37, 1.74) |
| 3rd Quartile | +0.03 (-0.43, 0.50) | +1.86 (-0.43, 4.16) | +0.05 (-1.71, 1.80) |
| 4th Quartile | -1.54 (-1.71, -1.37)¶ | +1.20 (-0.72, 3.12) | -1.42 (-2.75, -0.10)∥ |
*Beta coefficient with 95% confidence intervals was shown; †Model I: adjusted for age, gender, physical activity, smoking, height, serum total cholesterol (total-C), serum triglyceride and fasting glucose; ‡Model II: Model I + energy intake (total energy intake, total carbohydrate intake, total fat intake, total protein intake); §Model III: Model II + comorbidities (the presence of either CVD, arthritis, COPD, asthma or hypertension), For male: 1st quartile: total-C < 161, 2nd quartile: 161 ≤ total-C < 180, 3rd quartile: 180 ≤ total-C < 211, 4th quartile total-C ≥ 211, For female: 1st quartile: total-C < 145, 2nd quartile: 145 ≤ total-C < 182.5, 3rd quartile: 182.5≤ total-C < 208, 4th quartile total-C ≥ 208, For total subjects: 1st quartile: total-C< 156, 2nd quartile: 156 ≤ total-C < 180, 3rd quartile: 180 ≤ total-C < 209, 4th quartile total-C ≥ 209; ∥p < 0.05; ¶p < 0.001 compared to reference group of total-C within same sex or total subjects.